Srinagar (Jammu and Kashmir) [India], June 3 (ANI): The District Administration in Srinagar has assisted over 7000 non-Covid health emergencies and ailment cases, with assistance ranging from free dialysis, transportation, drugs, medical check-ups, hospital assistance, chemotherapies and oth
New Delhi [India], June 2 (ANI): In a significant development, the country's top drug controller the Central Drug Control Standard Organisation (CDCSO) has given permission to Gilead Sciences for marketing authorization of its anti-viral drug Remdesivir "only for restricted emergency use" o
California [USA], June 1 (ANI): Among patients with both colorectal cancer and diabetes in Korea, those who had high adherence to their oral diabetes medication had a significantly reduced risk of overall mortality compared with those with lower adherence, suggests a study.
New Delhi [India], June 1 (ANI): Citing noteworthy benefits of Hydroxychloroquine (HCQ) prophylaxis against coronavirus, the Indian Council of Medical Research (ICMR) has revealed that the consumption of four or more doses of the antimalarial drug- (HCQ), has shown a significant decline of C
Chandigarh (Haryana) [India], May 31 (ANI): Following an intensive and planned crackdown on drug peddlers, Haryana Police have seized a total of 2,179 kg of narcotic substances worth crores of rupees from across the state.
Washington D.C. [USA], May 31 (ANI): The findings of a recent study show that over the past decade -- women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enr
Nagoya [Japan] May 31 (ANI): Scientists have found that chemotherapy combined with drug "rituximab" coupled with treatment for the secondary Central Nervous System (CNS) problem, shows promising results for patients suffering from a rare subtype of Lymphoma (blood cancer).
Mumbai (Maharashtra) [India], May 29 (ANI): Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covid-19 patients.
New Delhi [India], May 28 (ANI): India is making efforts to develop vaccine to treat COVID-19 patients, which will cost USD 2-3 billion, said Prof K Vijay Raghavan, Principal Scientific Advisor (PSA) to the Government of India, here on Thursday.
New Delhi [India], May 28 (ANI): The All India Council for Technical Education (AICTE) and the Council of Scientific and Industrial Research (CSIR) have embarked on a drug discovery hackathon to fight against COVID-19, said Prof K Vijay Raghavan, Principal Scientific Advisor (PSA) to Gove
New Delhi [India], May 28 (ANI): The fight against coronavirus will be won through vaccine and drugs as India's science and technology institutions and pharma industry are very strong, said Dr VK Paul, Member, NITI Aayog and Chairman, Empowered Group 1, here on Thursday.